Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.
| Revenue (TTM) | $3.64B |
| Gross Profit (TTM) | $1.80B |
| EBITDA | $526.00M |
| Operating Margin | 9.24% |
| Return on Equity | -33.00% |
| Return on Assets | 1.96% |
| Revenue/Share (TTM) | $18.24 |
| Book Value | $6.58 |
| Price-to-Book | 1.71 |
| Price-to-Sales (TTM) | 0.61 |
| EV/Revenue | 1.203 |
| EV/EBITDA | 47.13 |
| Quarterly Earnings Growth (YoY) | 15.20% |
| Quarterly Revenue Growth (YoY) | -4.10% |
| Shares Outstanding | $199.35M |
| Float | $187.99M |
| % Insiders | 0.65% |
| % Institutions | 116.86% |
Volatility is currently contracting
DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its turnaround plan amid lower volumes in several businesses and distributor inventory reductions in Europe.
DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained.
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors.
CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.
This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients.
XRAY leans on its Return-to-Growth plan, new distributor wins and AI-enabled launches ??? while forex and Europe demand softness linger.
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on XRAY and any ticker you trade — then tracks every position and per-strategy win rate.
